A multiparameter whole blood platform for assessment of anti-CMV immunity in allogeneic stem cell transplantation recipients
A multiparameter HCMV-reactive whole blood (WB) assay that can be initiated at the bedside, requires minimal blood volume, preserves physiological cellular interactions, and enables integrated cellular and cytokine readouts within a closed-tube workflow is established.